Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2354 of 5804
-
Could stem cell vesicles treat spinal cord cavities?
Disease control OngoingThis is a open-label, single-arm, dose escalation phase I clinical trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of Intrathecal injection human umbilical cord-derived mesenchymal stromal cell-derived extracellular vesicle (hUC-MSC-sEV) …
Phase: PHASE1 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Blood cytokines may hold key to predicting vitiligo progression
Knowledge-focused Not yet recruitingVitiligo is a chronic autoimmune disorder characterized by depigmented patches on the skin, which can pose significant psychosocial challenges, particularly for individuals with darker skin tones. Compared to the general population, individuals with vitiligo are more likely to ex…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New shot for solid tumors enters early human testing
Disease control Recruiting nowThe study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can we fix iron in food for starving kids?
Knowledge-focused Recruiting nowReports from the Kenya Red Cross Society (KRCS) in Kwale County, southern Kenya, indicate a limited impact of Ready-to-Use Therapeutic Foods (RUTFs) on malnutrition or anemia. The current RUTF formulation may have an excessively high iron content. In severely acutely malnourished…
Phase: NA • Sponsor: ETH Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy for lung scarring and high blood pressure under study
Disease control Recruiting nowThis is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for DM1: Long-Term safety trial of PGN-EDODM1 now recruiting
Disease control Recruiting nowThe purpose of this study is to learn about the long-term safety and tolerability of PGN-EDODM1 in participants with myotonic dystrophy type 1 (DM1) who have completed a prior study with PGN-EDODM1.
Phase: PHASE2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New eye drops aim to halt keratoconus progression
Disease control Recruiting nowMulti-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.
Phase: PHASE2 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pill aimed at Hard-to-Treat GVHD enters early human testing
Disease control Recruiting nowOpen-label, dose escalation study to evaluate safety, tolerability pharmacokinetic and pharmacodynamic activity, and efficacy of Adrixetinib (Q702) in subjects with relapsed or refractory active chronic graft-versus-host disease (cGVHD).
Phase: PHASE1 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Peer coaches may boost opioid treatment success
Disease control Recruiting nowThe goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aim…
Phase: NA • Sponsor: Geisinger Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Virtual community aims to turn prediabetes around with games and peer support
Disease control CompletedThis study builds upon the previously developed virtual health community platform, aiming to address the group characteristics and psychological traits of prediabetic patients. By employing intervention mapping to construct a group interaction management model, it seeks to develo…
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Beetroot jelly could give swimmers a natural edge
Symptom relief CompletedSwimming requires high energy in a short time and involves overcoming water resistance. Besides regular training, swimmers use supplements to enhance performance, correct nutrient deficiencies, and speed recovery. The Australian Institute of Sport (AIS) classifies supplements by …
Phase: NA • Sponsor: Halic University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Sound waves and muscle zaps aim to tighten sagging skin without surgery
Symptom relief OngoingOpen-label, non-randomized single-arm prospective, single-center, self-controlled clinical study.
Phase: NA • Sponsor: Sofwave Medical LTD • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could probiotics and ginger soothe chronic stomach pain?
Symptom relief Recruiting nowFunctional dyspepsia (FD) is a frequent functional gastrointestinal disorder characterized by bothersome postprandial fullness, early satiety, epigastric pain, or burning, in the absence of any structural or metabolic cause. It significantly impairs quality of life and has limite…
Phase: NA • Sponsor: Biocodex • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New shot could tame stubborn high cholesterol
Disease control Recruiting nowStudy to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and effects on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) of single-dose ARO-DIMERPA and multiple doses of ARO-DIMERPA in adult participants with mixed hyperlipi…
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New schizophrenia pill shows promise in Long-Term safety trial
Disease control Recruiting nowTo evaluate the safety of SEP-363856 (75 mg/day or 100 mg/day) administered for 52 weeks in adult participants with schizophrenia
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Cosentyx under Real-World watch for kids and adults with skin and joint disease
Disease control Recruiting nowRegulatory Post-Marketing Surveillance in hidradenitis suppurativa, pediatric plaque psoriasis and JIA treated with Cosentyx®(secukinumab) in Korea
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New exercise study aims to stop postpartum leakage without surgery
Symptom relief OngoingPostpartum stress urinary incontinence is a widespread condition characterized by involuntary loss of urine during physical exertion, such as sneezing, coughing, or lifting heavy weights. Most frequently occur in multiparous women with vaginal delivery, who are obese, constipated…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can a smart app help teens breathe easier?
Symptom relief Recruiting nowAsthma affects nearly 1 in 10 teenagers in the United States and can seriously impact their health and daily life. Teens are expected to manage their asthma by taking medications correctly and paying attention to symptoms, but this can be hard. Adolescents are still developing th…
Phase: NA • Sponsor: University of Kansas • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Freezing nerves to ease CP pain: new hope for stuck muscles?
Symptom relief Recruiting nowThe main objective of this study is to evaluate the achievement of personalised short- and medium-term objectives of this selective treatment of hypertonia by ultrasound-guided perineural percutaneous cryoneurolysis at the shoulder and elbow, in a population of patients with cere…
Phase: NA • Sponsor: Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New nerve block may cut opioid use after cancer surgery
Symptom relief Recruiting nowPain accompanying Inguinal lymph node dissection triggers a complex stress response leading to impairment of pulmonary, immunological and metabolic function. Opioids are the current gold standard drug for postoperative pain relief, however exposure to large doses lead to multiple…
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC